TAFRO syndrome complicated by porto-sinusoidal vascular liver disease with portal hypertension: a case report-Reference-Cited by-同舟云学术

TAFRO syndrome complicated by porto-sinusoidal vascular liver disease with portal hypertension: a case report

Published:2021-09-06 Issue:6 Volume:14 Page:1711-1717
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Hayashi Manabu^ORCID,Wada Jun,Fujita Masashi,Asano Tomoyuki,Matsuoka Naoki,Fujita Yuya,Temmoku Jumpei,Matsumoto Haruki,Yashio-Furuya Makiko,Sato Shuzo,Kobayashi Hiroko,Watanabe Hiroshi,Ryoichiro Kobashi,Waragai Yuichi,Suzuki Erina,Kiko Yuichiro,Abe Kazumichi,Takahashi Atsushi,Masuda Tomoyuki,Hashimoto Yuko,Migita Kiyoshi,Ohira Hiromasa^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-021-01515-2.pdf

Reference21 articles.

1. Hernandez-Gea V, Baiges A, Turon F, et al. Idiopathic portal hypertension. Hepatology. 2018;68:2413–23.

2. De Gottardi A, Rautou PE, Schouten J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019;4:399–411.

3. Schouten JN, Nevens F, Hansen B, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther. 2012;35:1424–33.

4. Siramolpiwat S, Seijo S, Miquel R, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology. 2014;59:2276–85.

5. Paydas S. Tafro syndrome: critical review for clinicians and pathologists. Crit Rev Oncol Hematol. 2018;128:88–95.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus Treatment for TAFRO Syndrome;Biomedicines;2024-05-12

2. TAFRO syndrome: A disease that known is half cured;Hematological Oncology;2022-10-03

3. Multiple drugs;Reactions Weekly;2021-12